Literature DB >> 33118992

Changes in the uptake of screening for prostate cancer with prostate-specific antigen in Ontario between 2003 to 2012.

Louis Watson1.   

Abstract

OBJECTIVES: This study investigates change in prostate-specific antigen (PSA) screening uptake in Ontario among men 35 years of age and older, between 2003 and 2012. We identify factors related to PSA testing, and examine the degree to which age guidelines for PSA testing are being followed or if PSA screening is opportunistic in nature. The relationship of income, education and having a regular physician and an estimation of PSA testing prevalence in 2012 is also studied.
METHODS: Data from the Canadian Community Health Survey (CCHS) were used to estimate the proportion of men who had a PSA test in 2003 and then compared to a similar estimate (in similar population) in 2012. We also examined associations with PSA uptake to socio-demographic factors. Contingency table analyses were performed to characterize the changes; logistic regression was also used to evaluate the differences, while taking into account the possible confounding role of other factors.
RESULTS: We found among men aged 35-49 years and 75+, there was an increase in PSA utilization between 2003 and 2012. In 2003, 18% of men 35-49 years, and 74% of men aged 75+ reported ever having a PSA test. These figures increased to 20% of men aged 35-49 years, and 84% of men aged 75+ years in 2012. Logistic regression showed that a man in the 70-74 age category in 2012 had the highest likelihood of having had a PSA test compared to men in the age range of 35-49 years (odds ratio (OR)=25.9; confidence interval (CI)= 19.9-33.8).
CONCLUSION: In Ontario, PSA testing is seemingly opportunistic in nature and occurring in groups not recommended for testing by the Ontario guidelines. There is a marked increase in PSA utilization in age ranges outside of the current Ontario PSA testing guidelines (35-49 and 75+). It would appear that most PSA testing in Ontario is opportunistic and adherence to age guidelines is limited.
© 2020 Canadian Association of Nurses in Oncology (CANO).

Entities:  

Keywords:  Canada/Ontario; PSA test; cancer screening; cross-sectional study; prostate cancer

Year:  2020        PMID: 33118992      PMCID: PMC7586704          DOI: 10.5737/23688076302125132

Source DB:  PubMed          Journal:  Can Oncol Nurs J        ISSN: 1181-912X


  17 in total

1.  Prostate cancer screening: where are we now?

Authors:  Alexander Light; Oussama Elhage; Lorenzo Marconi; Prokar Dasgupta
Journal:  BJU Int       Date:  2019-02-19       Impact factor: 5.588

2.  Implications of false-positive results for future cancer screenings.

Authors:  Glen B Taksler; Nancy L Keating; Michael B Rothberg
Journal:  Cancer       Date:  2018-04-23       Impact factor: 6.860

3.  Lifetime and recent prostate specific antigen (PSA) screening of men for prostate cancer in Canada.

Authors:  Jennifer A Beaulac; Richard N Fry; Jay Onysko
Journal:  Can J Public Health       Date:  2006 May-Jun

Review 4.  Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Joshua J Fenton; Meghan S Weyrich; Shauna Durbin; Yu Liu; Heejung Bang; Joy Melnikow
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

5.  What Is the Effectiveness of Patient Decision Aids for Cancer-Related Decisions? A Systematic Review Subanalysis.

Authors:  Kristen McAlpine; Krystina B Lewis; Lyndal J Trevena; Dawn Stacey
Journal:  JCO Clin Cancer Inform       Date:  2018-12

6.  Recent trends in prostate cancer in Canada.

Authors:  Allana G LeBlanc; Alain Demers; Amanda Shaw
Journal:  Health Rep       Date:  2019-04-17       Impact factor: 4.796

7.  The economic burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.

Authors:  S A Grover; L Coupal; H Zowall; R Rajan; J Trachtenberg; M Elhilali; M Chetner; L Goldenberg
Journal:  CMAJ       Date:  2000-04-04       Impact factor: 8.262

8.  Men's information-seeking behavior regarding cancer risk and screening: A meta-narrative systematic review.

Authors:  Mohamad M Saab; Mary Reidy; Josephine Hegarty; Mairin O'Mahony; Mike Murphy; Christian Von Wagner; Frances J Drummond
Journal:  Psychooncology       Date:  2017-08-18       Impact factor: 3.894

9.  An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high?

Authors:  E Feletto; A Bang; D Cole-Clark; V Chalasani; K Rasiah; D P Smith
Journal:  World J Urol       Date:  2015-02-20       Impact factor: 4.226

10.  Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.

Authors:  S Michelle Driedger; Gary Annable; Melissa Brouwers; Donna Turner; Ryan Maier
Journal:  BMC Cancer       Date:  2017-09-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.